-
1
-
-
79952284127
-
Hallmarks of cancer: The next generation
-
Hanahan D., Weinberg R.-A. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
-
(2011)
Cell
, vol.144
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.-A.2
-
2
-
-
79961087495
-
Controvercies in clinical cancer dormancy
-
Uhr J. W., Pantel K. Controvercies in clinical cancer dormancy. Proc. Natl. Acad. Sci. USA. 2011;108:12396-400.
-
(2011)
Proc. Natl. Acad. Sci. USA.
, vol.108
, pp. 12396-12400
-
-
Uhr, J.W.1
Pantel, K.2
-
3
-
-
72249093615
-
Tumor self-seeding by circulating cancer cells
-
Kim M. Y., Oskarsson T., Acharyya S., Nguyen D. X., Zhang X. H., Norton L., Massague J. Tumor self-seeding by circulating cancer cells. Cell. 2009;139:1315-26.
-
(2009)
Cell.
, vol.139
, pp. 1315-1326
-
-
Kim, M.Y.1
Oskarsson, T.2
Acharyya, S.3
Nguyen, D.X.4
Zhang, X.H.5
Norton, L.6
Massague, J.7
-
5
-
-
23944466427
-
A pooled analysis of bone marrow micrometastasis in breast cancer
-
Braun S., Vogl F. D., Naume B., Janni W., Osborne M. P., Coombes R. C., et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N. Engl. J. Med. 2005;353:793-802.
-
(2005)
N. Engl. J. Med.
, vol.353
, pp. 793-802
-
-
Braun, S.1
Vogl, F.D.2
Naume, B.3
Janni, W.4
Osborne, M.P.5
Coombes, R.C.6
-
8
-
-
84863100828
-
Considerations in the development of circulating tumor cell technology for clinical use
-
Parkinson D. R., Dracopoli N., Gumbs Petty B., Compton C., Cris-tofanilli M., Deisseroth A. M. et al. Considerations in the development of circulating tumor cell technology for clinical use. J. Transl. Med. 2012;10:138.
-
(2012)
J. Transl. Med.
, vol.10
, pp. 138
-
-
Parkinson, D.R.1
Dracopoli, N.2
Gumbs Petty, B.3
Compton, C.4
Cris-tofanilli, M.5
Deisseroth, A.M.6
-
9
-
-
84863587972
-
Ultrasensitive clinical enumeration of rare cells ex vi9vo using a micro-Hall detector
-
Issadore D., Chung J., Shao H., Liong M., Ghazani A. A., Castro C. M., et al. Ultrasensitive clinical enumeration of rare cells ex vi9vo using a micro-Hall detector. Sci. Transl. Med. 2012;4:141.
-
(2012)
Sci. Transl. Med.
, vol.4
, pp. 141
-
-
Issadore, D.1
Chung, J.2
Shao, H.3
Liong, M.4
Ghazani, A.A.5
Castro, C.M.6
-
11
-
-
84868640644
-
Continuous labeling of circulating tumor cells with microbeads using a vortex micromixer for highly selective isolation
-
Lin M. X., Huyn K. A., Moon H. S., Sim T. S., Lee J. G., Park J. C. et al. Continuous labeling of circulating tumor cells with microbeads using a vortex micromixer for highly selective isolation. Biosens. Bioelectron. 2013;40:63-7.
-
(2013)
Biosens. Bioelectron.
, vol.40
, pp. 63-67
-
-
Lin, M.X.1
Huyn, K.A.2
Moon, H.S.3
Sim, T.S.4
Lee, J.G.5
Park, J.C.6
-
12
-
-
84860571431
-
EPISPOT assay: Detection of viable DTCs/CTCs in solid tumor patients
-
Alix-Panabieres C., EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients. Recent Results Cancer Res. 2012;195:69-76.
-
(2012)
Recent Results Cancer Res.
, vol.195
, pp. 69-76
-
-
Alix-Panabieres, C.1
-
13
-
-
74049140862
-
Full-length cytokeratin-19 is released by human tumor cells: A potential role in metastatic progression of breast cancer
-
Alix-Panabieres C., Vendrell J. P., Slijper M., Pelle O., Barbotte E., Mercier G. et al. Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer. Breast Cancer Res. 2009;11:R39.
-
(2009)
Breast Cancer Res.
, vol.11
-
-
Alix-Panabieres, C.1
Vendrell, J.P.2
Slijper, M.3
Pelle, O.4
Barbotte, E.5
Mercier, G.6
-
14
-
-
33947420824
-
Detection and characterization of putative metastatic precursor cells in cancer patients
-
Alix-Panabieres C., Vendrell J. P., Pelle O., Rebillard X., Riethdorf S., Muller V. et al. Detection and characterization of putative metastatic precursor cells in cancer patients. Clin. Chem. 2007;53:537-9.
-
(2007)
Clin. Chem.
, vol.53
, pp. 537-539
-
-
Alix-Panabieres, C.1
Vendrell, J.P.2
Pelle, O.3
Rebillard, X.4
Riethdorf, S.5
Muller, V.6
-
15
-
-
79959228670
-
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology
-
Somlo G., Lau S. K., Frankel P., Hsieh H. B., Liu X., Yang L. Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/ inflammatory, and stage IV breast cancer, using a novel detection technology. Breast. Cancer Res. Treat. 2011 128:155-63.
-
(2011)
Breast. Cancer Res. Treat.
, vol.128
, pp. 155-163
-
-
Somlo, G.1
Lau, S.K.2
Frankel, P.3
Hsieh, H.B.4
Liu, X.5
Yang, L.6
-
16
-
-
50249146385
-
Detection of circulating tumor cells in peripheral blood with an automated scanning fluorescent microscope
-
Ntouroupli T. G., Ashraf S. Q., McGregor S. B., Turney B. W., Seppo A., Kim Y. et al. Detection of circulating tumor cells in peripheral blood with an automated scanning fluorescent microscope. Br. J. Cancer. 2008;99:789-95.
-
(2008)
Br. J. Cancer.
, vol.99
, pp. 789-795
-
-
Ntouroupli, T.G.1
Ashraf, S.Q.2
McGregor, S.B.3
Turney, B.W.4
Seppo, A.5
Kim, Y.6
-
17
-
-
42649100970
-
Detection, clinical relevance and specific biological propertiesof disseminating tumor cells
-
Pantel K., Brakenhoff R. H., Brandt B. Detection, clinical relevance and specific biological propertiesof disseminating tumor cells. Nat. Rev. Cancer. 2008;8:329-40.
-
(2008)
Nat. Rev. Cancer.
, vol.8
, pp. 329-340
-
-
Pantel, K.1
Brakenhoff, R.H.2
Brandt, B.3
-
18
-
-
80052190496
-
Circulating tumor cells in breast cancer: Detection systems, molecular characterization and future challenges
-
Lianidou E. S., Markou A. Circulating tumor cells in breast cancer: detection systems, molecular characterization and future challenges. Clin. Chem. 2011;57:1242-57.
-
(2011)
Clin. Chem.
, vol.57
, pp. 1242-1257
-
-
Lianidou, E.S.1
Markou, A.2
-
19
-
-
43049165453
-
The epithelial-mesenchymal transition generate cells with properties of stem cells
-
Mani S., Guo W., Liao M. J., Eaton E. N., Ayyanan A., Zhou A. Y. et al. The epithelial-mesenchymal transition generate cells with properties of stem cells. Cell. 2008;133:704-15.
-
(2008)
Cell.
, vol.133
, pp. 704-715
-
-
Mani, S.1
Guo, W.2
Liao, M.J.3
Eaton, E.N.4
Ayyanan, A.5
Zhou, A.Y.6
-
20
-
-
79952239863
-
Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay
-
Maikou A., Strati A., Malamos N., Georgoulias V., Lianidou E. S. Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay. Clin. Chem. 2011;57:421-30.
-
(2011)
Clin. Chem.
, vol.57
, pp. 421-430
-
-
Maikou, A.1
Strati, A.2
Malamos, N.3
Georgoulias, V.4
Lianidou, E.S.5
-
22
-
-
0032531005
-
DExpression of MUC1 mucin on activated human T cells: Implications for a role of MUCI in normal immune regulation
-
Agrawal B., Krantz MJ., Parker J., Longenecker B. M. DExpression of MUC1 mucin on activated human T cells: implications for a role of MUCI in normal immune regulation. Cancer Res. 1998;58:4079-81.
-
(1998)
Cancer Res.
, vol.58
, pp. 4079-4081
-
-
Agrawal, B.1
Krantz, M.J.2
Parker, J.3
Longenecker, B.M.4
-
23
-
-
79960840056
-
A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients
-
Kim S. J., Masago A., Tamaki Y., Akazawa K., Tsukamoto F., Sato J. et al. A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients. Breast Cancer Res. Treat. 2011;128:765-73.
-
(2011)
Breast Cancer Res. Treat.
, vol.128
, pp. 765-773
-
-
Kim, S.J.1
Masago, A.2
Tamaki, Y.3
Akazawa, K.4
Tsukamoto, F.5
Sato, J.6
-
24
-
-
84866509291
-
A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire
-
Saucedo-Zeni N., Mewes S., Niestroj R., Casiorowski L., Murawa D., Nowaczyk P., et al. A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire. Int. J. Oncol. 2012;16.
-
(2012)
Int. J. Oncol.
, pp. 16
-
-
Saucedo-Zeni, N.1
Mewes, S.2
Niestroj, R.3
Casiorowski, L.4
Murawa, D.5
Nowaczyk, P.6
-
25
-
-
79951902192
-
Enrichment of circulating tumor cells from a large blood volume using leukapheresis and elutriation: Proof of concept
-
Eifler R. L., Lind J., Falkenhagen D., Weber V., Fischer M. B., Zeil-linger R., Enrichment of circulating tumor cells from a large blood volume using leukapheresis and elutriation: proof of concept. Cytometry B Clin. Cytom. 2011;80:100-11.
-
(2011)
Cytometry B Clin. Cytom.
, vol.80
, pp. 100-111
-
-
Eifler, R.L.1
Lind, J.2
Falkenhagen, D.3
Weber, V.4
Fischer, M.B.5
Zeil-linger, R.6
-
26
-
-
80052428699
-
The social aspects of EMT-MET plasticity
-
Thompson E. W., Haviv I. The social aspects of EMT-MET plasticity. Nat. Med 2011;17:1048-9.
-
(2011)
Nat. Med
, vol.17
, pp. 1048-1049
-
-
Thompson, E.W.1
Haviv, I.2
-
27
-
-
84867985453
-
Plasticity of disseminating cancer cells in patients with epithelial malignancies
-
Bednarz-Knoll N., Alix-Panabieres C., Pantel K. Plasticity of disseminating cancer cells in patients with epithelial malignancies. Cancer Metastasis Rev. 2012;31:673-87.
-
(2012)
Cancer Metastasis Rev.
, vol.31
, pp. 673-687
-
-
Bednarz-Knoll, N.1
Alix-Panabieres, C.2
Pantel, K.3
-
28
-
-
79955420293
-
Cancer theory faces doubts
-
Ledflord H. Cancer theory faces doubts. Nature. 2011;472:273.
-
(2011)
Nature
, vol.472
, pp. 273
-
-
Ledflord, H.1
-
29
-
-
77954233490
-
BRCAI loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood
-
Bednarz N., Eltze E., Semjonow A., Rink M., Andreas A., Mulder L. et al. BRCAI loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood. Clin. Cancer Res. 2010;16:3340-8.
-
(2010)
Clin. Cancer Res.
, vol.16
, pp. 3340-3348
-
-
Bednarz, N.1
Eltze, E.2
Semjonow, A.3
Rink, M.4
Andreas, A.5
Mulder, L.6
-
30
-
-
4143094988
-
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
-
Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 2004;351:781-91.
-
(2004)
N. Engl. J. Med.
, vol.351
, pp. 781-791
-
-
Cristofanilli, M.1
Budd, G.T.2
Ellis, M.J.3
Stopeck, A.4
Matera, J.5
Miller, M.C.6
-
31
-
-
84860660477
-
Circulating epithelial cells in patients with benign colon diseases
-
Pantel K, Deneve E, Nocca D, Coffy A, Vendrell JP, Maudelonde T, et al. Circulating epithelial cells in patients with benign colon diseases. Clin. Chem. 2012;58:936-40.
-
(2012)
Clin. Chem.
, vol.58
, pp. 936-940
-
-
Pantel, K.1
Deneve, E.2
Nocca, D.3
Coffy, A.4
Vendrell, J.P.5
Maudelonde, T.6
-
32
-
-
43049087002
-
Tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: Initial results in early prostate cancer
-
discussion 2191
-
Davis J. W., Nakanishi H., Kumar V. S., Bhadkamkar V. A., McCormack R., Fitsche H. A. et al. tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer. J. Urol. 2008;179:2187-91, discussion 2191.
-
(2008)
J. Urol.
, vol.179
, pp. 2187-2191
-
-
Davis, J.W.1
Nakanishi, H.2
Kumar, V.S.3
Bhadkamkar, V.A.4
McCormack, R.5
Fitsche, H.A.6
-
33
-
-
84856088337
-
EMT and dissemination precede pancreatic tumor formation
-
Rhim A. D., Mirek E. T., Aiello N. M., Maitra A., Bailey J. M., McAllister F., et al. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148:349-61.
-
(2012)
Cell.
, vol.148
, pp. 349-361
-
-
Rhim, A.D.1
Mirek, E.T.2
Aiello, N.M.3
Maitra, A.4
Bailey, J.M.5
McAllister, F.6
-
34
-
-
84860678582
-
Circulating tumor cells - New challenges ahead
-
Lianidou E. S. Circulating tumor cells - new challenges ahead. Clin. Chem. 2012;58:805-7.
-
(2012)
Clin. Chem.
, vol.58
, pp. 805-807
-
-
Lianidou, E.S.1
-
35
-
-
73449133770
-
Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis
-
Stoecklein NH, Klein CA. Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis. Int. J. Cancer. 2010;126:589-98.
-
(2010)
Int. J. Cancer.
, vol.126
, pp. 589-598
-
-
Stoecklein, N.H.1
Klein, C.A.2
-
36
-
-
77956268304
-
Circulating tumour cells in cancer patients: Challenges and perspectives
-
Pantel K., Alix-Panabieres C.. Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol. Med. 2010;16:398-406.
-
(2010)
Trends Mol. Med.
, vol.16
, pp. 398-406
-
-
Pantel, K.1
Alix-Panabieres, C.2
-
37
-
-
63049102497
-
Parallel progression of primary tumours and metastases
-
Klein C. A. Parallel progression of primary tumours and metastases. Nat. Rev. Cancer. 2009;9:302-12.
-
(2009)
Nat. Rev. Cancer.
, vol.9
, pp. 302-312
-
-
Klein, C.A.1
-
38
-
-
77951740458
-
Detection and HER2 expression of circulating tumour cells: Prospective monitoring in breast cancer patients treated in the neoadjuvant Gepar Quatro trial
-
Riethdorf S., Muller V., Zhang L., Rau T., Loibl S., Komor M. et al. Detection and HER2 expression of circulating tumour cells: prospective monitoring in breast cancer patients treated in the neoadjuvant Gepar Quatro trial. Clin. Cancer Res. 2010;16:2634-45.
-
(2010)
Clin. Cancer Res.
, vol.16
, pp. 2634-2645
-
-
Riethdorf, S.1
Muller, V.2
Zhang, L.3
Rau, T.4
Loibl, S.5
Komor, M.6
-
39
-
-
33645688204
-
HER2 positive circulating tumour cells indicate poor clinical outcome in stage I to III breast cancer patients
-
Wulfing P., Borchard J., Buerger H., Heidi S., Zanker K. S., Kiesel L., Brandt B. HER2 positive circulating tumour cells indicate poor clinical outcome in stage I to III breast cancer patients. Clin. Cancer Res. 2006;12:1715-20.
-
(2006)
Clin. Cancer Res.
, vol.12
, pp. 1715-1720
-
-
Wulfing, P.1
Borchard, J.2
Buerger, H.3
Heidi, S.4
Zanker, K.S.5
Kiesel, L.6
Brandt, B.7
-
40
-
-
79251548904
-
HER2 positive circulating tumour cells in breast cancer
-
Ignatiadis M., Rothe F., Chaboteaux C., Durbacq V., Rouas G., Cris-tiiello C. et al. HER2 positive circulating tumour cells in breast cancer. PLoS One. 2011;6el 5624.
-
(2011)
PLoS One
-
-
Ignatiadis, M.1
Rothe, F.2
Chaboteaux, C.3
Durbacq, V.4
Rouas, G.5
Cris-tiiello, C.6
-
41
-
-
82355170196
-
Quantitative high-resolution genomic analysis of single cancer cells
-
Hannemann J., Meyer-Staeckling S., Kemming D., Alpers I., Joosse S. A., Pospisil H. et al. Quantitative high-resolution genomic analysis of single cancer cells. PLoS One. 2011;6 e26362.
-
(2011)
PLoS One
, vol.6
-
-
Hannemann, J.1
Meyer-Staeckling, S.2
Kemming, D.3
Alpers, I.4
Joosse, S.A.5
Pospisil, H.6
-
42
-
-
84864302254
-
Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy resistant. CKl9mRNA-positive. Circulating tumour cells: Results of a randomized phase II study
-
Georgoulias V., Bozionelou V., Agelaki S., Perraki M., Apostolaki S., Kallergi G. et al. Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy resistant. CKl9mRNA-positive. circulating tumour cells: results of a randomized phase II study. Ann. Oncol 2012;23:1744-50.
-
(2012)
Ann. Oncol
, vol.23
, pp. 1744-1750
-
-
Georgoulias, V.1
Bozionelou, V.2
Agelaki, S.3
Perraki, M.4
Apostolaki, S.5
Kallergi, G.6
-
43
-
-
79955016306
-
Circulating tumour cells: Not all detected cells are bad and not all bad cells are detected
-
Wicha M. S., Hayes D. F. Circulating tumour cells: Not all detected cells are bad and not all bad cells are detected. J. Clin. Oncol. 2011;29:1508-1.
-
(2011)
J. Clin. Oncol.
, vol.29
, pp. 1508-1501
-
-
Wicha, M.S.1
Hayes, D.F.2
-
44
-
-
84863000299
-
The molecular evolution of acquired resistance in targeted EGFR blockade in colorectal cancers
-
Diaz L A. Jr, Williams R. T., Wu J., Kinde L., Hecht J. R., Berlin J. et al. The molecular evolution of acquired resistance in targeted EGFR blockade in colorectal cancers. Nature. 2012;486:537-40.
-
(2012)
Nature
, vol.486
, pp. 537-540
-
-
Diaz Jr., L.A.1
Williams, R.T.2
Wu, J.3
Kinde, L.4
Hecht, J.R.5
Berlin, J.6
-
45
-
-
79957458567
-
Cell-free nucleus acids as biomarkers in cancer patients
-
Schwarzenbach H., Hoon D. S., Pantel K. Cell-free nucleus acids as biomarkers in cancer patients. Nat. Rev. Cancer. 2001;1:426-37.
-
(2001)
Nat. Rev. Cancer.
, vol.1
, pp. 426-437
-
-
Schwarzenbach, H.1
Hoon, D.S.2
Pantel, K.3
|